Vaishali Pharma Ltd.

7.31

0 (-0.1%)stock indicator image for downward trend

As on July 3, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap95 Cr
P/E Ratio116.59
Dividend YieldN/A
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

This image for unlock stock of the monthUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open7.45
High7.49
NSE SymbolVAISHALI
Close7.31
Low7.15
BSE Symbol
Previous Years High/Low
1 Year High13.59
3 Year High24.91
5 Year High24.91
1 Year Low4.75
3 Year Low4.75
5 Year Low2.89

Technicals


IndicatorsValueSignal
5-DMA7.34Bearish
10-DMA7.38Bearish
20-DMA7.33Bearish
50-DMA7.36Bearish
100-DMA7.11Bullish
200-DMA8.39Bearish

Historical Performance


1 Year
-36.2%
3 Years
-41.6%
5 Years
65.9%
10 Years
N/A

Shareholding Pattern


%

Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:N/A
5 Years:11.6
3 Years:-15.5
TTM:-36.1
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 116.59, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered a weak 3-year price CAGR of -15.5%, indicating poor shareholder returns.
  • The stock carries a beta of 1.1, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹38 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹990 million, indicating a relatively small business scale.

Investment Calculator


Investment Amount: ₹ 1000000
Current Value: ₹ 618967
No. of Shares: 84674 (Approx)
Performance:-38.1%
P/L: ₹-381033
NIFTY Performance: -4.7%
1 day Top Gainers
SymbolChange%
SUMICHEM502.3(14%)
ZENSARTECH516.1(10%)
AEGISVOPAK257.43(10%)
ECLERX1488.8(7%)
KAYNES3333.8(6%)
1 Day Top Losers
SymbolChange%
GVT&D4401.5(-9%)
POWERINDIA31040(-8%)
ENRIN3281.5(-8%)
CGPOWER892.55(-7%)
UNIONBANK163.09(-7%)
THERMAX4607.5(-6%)
APARINDS14174(-6%)
TARIL336.75(-6%)

Top Performing Stocks from the same sector


Beta Drugs Ltd.

43.8%

2090.5

1 Month Performance

Bafna Pharmaceuticals Ltd.

41.8%

216.45

1 Month Performance

Ind-Swift Laboratories Ltd.

36.3%

214.16

1 Month Performance

Amanta Healthcare Ltd.

33.3%

163.09

1 Month Performance

Senores Pharmaceuticals Ltd.

32.2%

1381.9

1 Month Performance

Morepen Laboratories Ltd.

30.1%

59.07

1 Month Performance

Caplin Point Laboratories Ltd.

28.6%

2538.1

1 Month Performance

Panacea Biotec Ltd.

27.1%

551.2

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month